Effects of Combination Therapy with Liraglutide and Insulin Glargine as the Initial Treatment for Hyperglycemic Patients with Type 2 Diabetes: An Observational Study

doi:10.15344/2394-1499/2016/121

Graphy

Profile

New User

New to Graphy Publications? Create an account to get started today.

Create Account For:

Registered Users

Have an account? Sign in now.

Article Menu

Journal Menu

In Collaboration With

How to Cite | Author Information | Publication History

International Journal of Diabetes & Clinical Diagnosis Volume 3 (2016), Article ID 3:IJDCD-121, 3 pages
http://dx.doi.org/10.15344/2394-1499/2016/121

Short Communication

Effects of Combination Therapy with Liraglutide and Insulin Glargine as the Initial Treatment for Hyperglycemic Patients with Type 2 Diabetes: An Observational Study

Kotaro Kurasaki, Ikue Kigawa, Emi Sohara and Kumiko Hamano^*

Department of Diabetes and Endocrinology, Kanto Rosai Hospital, 1-1 Kizukisumiyoshi, Nakahara, Kawasaki, Kanagawa 211-8510, Japan

Corresponding Author Details: Prof. Kumiko Hamano, Department of Diabetes and Endocrinology, Kanto Rosai Hospital, 1-1 Kizukisumiyoshi, Nakahara, Kawasaki, Kanagawa 211-8510, Japan; E-mail: k-hamano@kantoh.rofuku.go.jp

Received: 06 September 2016; Accepted: 13 December 2016; Published: 15 December 2016

Citation: Kurasaki K, Kigawa I, Sohara E, Hamano K (2016) Effects of Combination Therapy with Liraglutide and Insulin Glargine as the Initial Treatment for Hyperglycemic Patients with Type 2 Diabetes: An Observational Study. Int J Diabetes Clin Diagn 3: 121. doi: http://dx.doi.org/10.15344/2394-1499/2016/121

Copyright: © 2016 Kurasaki et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res ClinPract 28:103-117. View
Vora J (2013) Combining incretin-based therapies with insulin: realizing the potential in type 2 diabetes. Diabetes Care 36 Suppl 2: S226-232. View
Balena R, Hensley IE, Miller S, Barnett AH (2013) Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature. Diabetes Obes Metab 15: 485-502. View
Holst JJ, Vilsbøll T (2013) Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings. Diabetes Obes Metab 15: 3-14. View
Eng C, Kramer CK, Zinman B, Retnakaran R (2014) Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis. Lancet 384: 2228-2234. View
Lane W, Weinrib S, Rappaport J (2011) The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements. Diabetes Technol Ther 13: 592-595. View
Li CJ, Li J, Zhang QM, Lv L, Chen R, et al. (2012) Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity. Cardiovasc Diabetol 11: 142. View
Ahmann A, Rodbard HW, Rosenstock J, Lahtela JT, de Loredo L, et al. (2015) Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial. Diabetes ObesMetab 17: 1056-1064. View

Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version